Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Pharmaceutica Sinica ; (12): 66-71, 2012.
Article Dans Chinois | WPRIM | ID: wpr-323079

Résumé

An efficient modified route based on the targeting mechanism of antibacterial fluoroquinolones for the shift from the antibacterial activity to the antitumor one was further developed. Using a fused heterocyclic ring, s-triazolothiadiazine as a carboxyl bioisostere of ciprofloxacin, the title compounds, 1-cyclopropyl-6-fluoro-7-piperazin-1-yl-3-(6-substituted-phenyl-7H-[1, 2, 4]triazolo[3, 4-b][1, 3, 4]thiadiazin-3-yl)-quinolin-4(1H)-ones (5a-5e) and their corresponding N-acetyl products (6a-6e), were designed and synthesized, separately. Meaningfully, a ring-contraction of fused six-membered thiadiazine occurred by a sulfur extrusion reaction gave new tri-acetylated fused heterocycles related to pyrazolo[5, 1-c][1, 2, 4] triazoles (7a-7e). The in vitro antitumor activity against L1210, CHO and HL60 cell lines was also evaluated for the synthesized fifteen heterocycles compared to parent ciprofloxacin by methylthiazole trazolium (MTT) assay. Interestingly, the results displayed that fifteen fused heterocyclic compounds showed more significant growth inhibitory activity (IC50 < 25.0 micromo x L(-1)) than that of parent ciprofloxacin (IC50 > 150.0 micromol x L(-1)), and the active order decreased from 7a-7e to 5a-5e to 6a-6e, respective.


Sujets)
Animaux , Cricetinae , Humains , Souris , Antinéoplasiques , Chimie , Pharmacologie , Cellules CHO , Lignée cellulaire tumorale , Ciprofloxacine , Pharmacologie , Cricetulus , Fluoroquinolones , Chimie , Pharmacologie , Cellules HL-60 , Concentration inhibitrice 50 , Leucémie L1210 , Anatomopathologie , Relation structure-activité , Thiadiazines , Chimie , Pharmacologie , Triazoles , Chimie , Pharmacologie
2.
Acta Pharmaceutica Sinica ; (12): 1017-1022, 2012.
Article Dans Anglais | WPRIM | ID: wpr-276206

Résumé

To explore an efficient strategy for further development of anticancer fluoroquinolone candidates derived from ciprofloxacin, a heterocyclic ring as the bioisosteric replacement of C3 carboxyl group led to a key intermediate, oxadiazole thiol (5), which was further modified to the bis-oxadiazole methylsulfides (7a-7h) and the corresponding dimethylpiperazinium iodides (8a-8h), respectively. Structures were characterized by elemental analysis and spectra data, and their anticancer activities in vitro against CHO, HL60 and L1210 cancer cells were also evaluated by MTT assay. The preliminary results show that piperazinium compounds (8) possess more potent activity than that of corresponding free bases (7).


Sujets)
Animaux , Cricetinae , Humains , Antinéoplasiques , Chimie , Pharmacologie , Cellules CHO , Lignée cellulaire tumorale , Prolifération cellulaire , Ciprofloxacine , Chimie , Cricetulus , Conception de médicament , Cellules HL-60 , Concentration inhibitrice 50 , Leucémie L1210 , Structure moléculaire , Oxadiazoles , Chimie , Pharmacologie , Pipérazines , Chimie , Pharmacologie
SÉLECTION CITATIONS
Détails de la recherche